Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.

PLoS One · 2018 · PMC6117011 · PMID 30161264

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, as in the case of the in vitro data, a clear trend can be observed in the lag time between the core-shell formulations containing PLGA 50:50 and PLGA 100:0 as barrier.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.